# Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study

> **NCT06039748** · — · COMPLETED · sponsor: **Shenzhen Raysight Intelligent Medical Technology Co., Ltd.** · enrollment: 330 (actual)

## Conditions studied

- Coronary Artery Disease
- Heart Diseases
- Cardiovascular Diseases
- Arteriosclerosis
- Coronary Stenosis
- Vascular Diseases
- Ischemia

## Interventions

- **OTHER:** AngioQFA

## Key facts

- **NCT ID:** NCT06039748
- **Lead sponsor:** Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-13
- **Primary completion:** 2024-01-14
- **Final completion:** 2024-01-14
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06039748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06039748, "Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06039748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*